STING1 and neoplasm: To further validate STING activation in primary antigen-presenting cells, we first treated MC38 tumor cells as described above and then added BMDCs to dying tumor cells, a procedure mimicking fresh APCs are recruited to the damaged tumor tissue where they can acquire DNA from dying tumor cells25.